Aundrea L Oliver1, Caitlin Takahashi-Pipkin2, Jan H Wong3, Ashley E Burch4,5, William D Irish6,7. 1. Department of Cardiovascular Science, Division of Thoracic Surgery, Brody School of Medicine at East, Carolina University, Greenville, NC, USA. 2. Department of Surgery, Brody School of Medicine at East, Carolina University, Greenville, NC, USA. 3. Department of Surgery, Division of Surgical Research, Brody School of Medicine at East Carolina University, Greenville, NC, USA. wongj@ecu.edu. 4. Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, USA. 5. Department of Health Services and Information Management, East Carolina University, Greenville, NC, USA. 6. Department of Surgery, Division of Surgical Research, Brody School of Medicine at East Carolina University, Greenville, NC, USA. 7. Department of Public Health, East Carolina University, Greenville, NC, USA.
Abstract
PURPOSE: Disparities in access to surgical care are associated with poorer outcomes in patients with cancer. We sought to determine whether vulnerable populations undergo an expected rate of surgery for Stage I-IIIA lung cancer in North Carolina (NC). METHODS: We calculated the proportional surgical ratio (PSR) to identify a potential disparity in surgery rates for early stage (I-IIIA) lung cancer, first in the five counties with the worst health outcomes (LRC) and subsequently the entire state. The reference was the five healthiest counties (HRC), initially, and then the single county with the best health outcomes. RESULTS: In 2016, 3,452 individuals with Stage I-IIIA lung cancer were diagnosed in NC of which 246,854 resided in LRC, whereas 1,865,588 resided in HRC. A total of 453 operable lung cancers were diagnosed in the HRC and 107 in the LRC. The observed lobectomy rate in HRC was 40.1% (range 20.2-58.3%) of early-stage lung cancer and 19% (range 12-36%) for LRC. The PSR was 0.65 (95% confidence interval [CI] = 0.35, 0.90). For all 99 counties across NC, the PSR ranged from 0.33 to 0.96 (mean = 0.49, standard deviation [SD] = 0.10). In a multivariable model, only other primary care provider ratio (relative rate per 100 increase = 0.997; 95% CI = 0.994, 0.999) was significantly associated with PSR. CONCLUSIONS: Individuals residing in LRC in NC are 42% less likely to undergo surgery for operable lung cancer than patients living in HRC. Understanding how factors impact access is key to designing informed interventions.
PURPOSE: Disparities in access to surgical care are associated with poorer outcomes in patients with cancer. We sought to determine whether vulnerable populations undergo an expected rate of surgery for Stage I-IIIA lung cancer in North Carolina (NC). METHODS: We calculated the proportional surgical ratio (PSR) to identify a potential disparity in surgery rates for early stage (I-IIIA) lung cancer, first in the five counties with the worst health outcomes (LRC) and subsequently the entire state. The reference was the five healthiest counties (HRC), initially, and then the single county with the best health outcomes. RESULTS: In 2016, 3,452 individuals with Stage I-IIIA lung cancer were diagnosed in NC of which 246,854 resided in LRC, whereas 1,865,588 resided in HRC. A total of 453 operable lung cancers were diagnosed in the HRC and 107 in the LRC. The observed lobectomy rate in HRC was 40.1% (range 20.2-58.3%) of early-stage lung cancer and 19% (range 12-36%) for LRC. The PSR was 0.65 (95% confidence interval [CI] = 0.35, 0.90). For all 99 counties across NC, the PSR ranged from 0.33 to 0.96 (mean = 0.49, standard deviation [SD] = 0.10). In a multivariable model, only other primary care provider ratio (relative rate per 100 increase = 0.997; 95% CI = 0.994, 0.999) was significantly associated with PSR. CONCLUSIONS: Individuals residing in LRC in NC are 42% less likely to undergo surgery for operable lung cancer than patients living in HRC. Understanding how factors impact access is key to designing informed interventions.
Authors: Shraddha M Dalwadi; Gary D Lewis; Eric H Bernicker; E Brian Butler; Bin S Teh; Andrew M Farach Journal: Clin Lung Cancer Date: 2018-11-20 Impact factor: 4.785
Authors: David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica R Bauman; Ankit Bharat; Debora S Bruno; Joe Y Chang; Lucian R Chirieac; Thomas A D'Amico; Thomas J Dilling; Jonathan Dowell; Scott Gettinger; Matthew A Gubens; Aparna Hegde; Mark Hennon; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Jules Lin; Billy W Loo; Christine M Lovly; Renato G Martins; Erminia Massarelli; Daniel Morgensztern; Thomas Ng; Gregory A Otterson; Sandip P Patel; Gregory J Riely; Steven E Schild; Theresa A Shapiro; Aditi P Singh; James Stevenson; Alda Tam; Jane Yanagawa; Stephen C Yang; Kristina M Gregory; Miranda Hughes Journal: J Natl Compr Canc Netw Date: 2021-03-02 Impact factor: 11.908
Authors: Mary Halter; Vari Drennan; Kaushik Chattopadhyay; Wilfred Carneiro; Jennifer Yiallouros; Simon de Lusignan; Heather Gage; Jonathan Gabe; Robert Grant Journal: BMC Health Serv Res Date: 2013-06-18 Impact factor: 2.655